Nolasiban

DB16259InvestigationalSmall molecule

Nolasiban is under investigation in clinical trial NCT03081208 (Phase 3 Placebo Controlled Study of Nolasiban to Improve Pregnancy Rates in Women Undergoing IVF/ICSI).

Mechanism: Pharmacologically active on Oxytocin receptor
Curator reviewed
Formula / weight: C₂₀H₂₂N₂O₃ · 338.407 g/mol (avg)
Also known as: Erlosiban

Resolves to

Compound

UNII3765U8A1ECCAS1477482-19-1ChEMBLCHEMBL1254025

Structure

InChIKeyOLUJSZLBWZWGJT-HGBKYHTQSA-NSMILESCO\N=C1\C[C@@H](CO)N(C1)C(=O)C1=CC=C(C=C1)C1=C(C)C=CC=C1

Targets

P30559OXTR

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

1Clinical trialPhase, status and sponsor resolved per trial

2+ReferencesStructured and connected to the statements they support

Which drugs share a target with Nolasiban, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account